Detalhe da pesquisa
1.
Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies.
Pharmacol Res
; 173: 105702, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102228
2.
Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions.
Drug Discov Today
; 27(1): 246-256, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34438075
3.
Inhibiting Eukaryotic Elongation Factor 2 Kinase: An Update on Pharmacological Small-Molecule Compounds in Cancer.
J Med Chem
; 64(13): 8870-8883, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162208
4.
Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications.
Front Mol Biosci
; 8: 790172, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988120
5.
Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy.
Front Pharmacol
; 12: 748149, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34512368
6.
Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy.
Acta Pharm Sin B
; 11(1): 156-180, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532187
7.
Identification of autophagic target RAB13 with small-molecule inhibitor in low-grade glioma via integrated multi-omics approaches coupled with virtual screening of traditional Chinese medicine databases.
Cell Prolif
; 54(12): e13135, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34632655
8.
Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.
Theranostics
; 10(19): 8880-8902, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32754285